LONGO, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 2.784
NA - Nord America 2.054
AS - Asia 1.309
SA - Sud America 192
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 21
OC - Oceania 1
Totale 6.450
Nazione #
RU - Federazione Russa 2.019
US - Stati Uniti d'America 1.969
SG - Singapore 442
IT - Italia 306
CN - Cina 282
IE - Irlanda 200
HK - Hong Kong 194
VN - Vietnam 188
BR - Brasile 151
DE - Germania 89
KR - Corea 70
GB - Regno Unito 48
IN - India 48
CA - Canada 42
FR - Francia 28
AR - Argentina 20
JP - Giappone 20
NL - Olanda 16
FI - Finlandia 11
MX - Messico 11
BD - Bangladesh 10
PL - Polonia 10
CZ - Repubblica Ceca 9
TR - Turchia 9
ZA - Sudafrica 9
EC - Ecuador 8
AT - Austria 6
CR - Costa Rica 6
IL - Israele 6
UA - Ucraina 6
IQ - Iraq 5
LT - Lituania 5
PK - Pakistan 5
PT - Portogallo 5
SE - Svezia 5
TT - Trinidad e Tobago 5
BE - Belgio 4
CO - Colombia 4
ID - Indonesia 4
SV - El Salvador 4
CH - Svizzera 3
CL - Cile 3
ES - Italia 3
GP - Guadalupe 3
GR - Grecia 3
HN - Honduras 3
IR - Iran 3
KE - Kenya 3
MY - Malesia 3
PR - Porto Rico 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
JM - Giamaica 2
KG - Kirghizistan 2
MA - Marocco 2
NI - Nicaragua 2
PY - Paraguay 2
TN - Tunisia 2
TW - Taiwan 2
VE - Venezuela 2
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 6.361
Città #
Moscow 756
San Jose 318
Singapore 246
Ashburn 230
Dublin 199
Hong Kong 187
Santa Clara 157
Council Bluffs 125
Chandler 117
Seoul 70
Beijing 68
Ho Chi Minh City 65
New York 65
Hefei 56
Naples 54
Los Angeles 53
Milan 40
Dallas 39
Hanoi 39
Munich 35
Bengaluru 26
Da Nang 26
North Bergen 24
Bremen 22
Orem 22
Princeton 21
San Francisco 20
Roxbury 19
São Paulo 18
Cambridge 17
Phoenix 17
Montreal 14
Atlanta 13
London 13
The Dalles 13
Chicago 12
Brooklyn 11
Miano 11
Rome 11
Denver 10
Toronto 10
Boston 9
Salerno 9
Aversa 8
Ercolano 8
Boardman 7
Brno 7
Bến Tre 7
Frankfurt am Main 7
Hillsboro 7
Marigliano 7
Warsaw 7
Amsterdam 6
Buffalo 6
Lappeenranta 6
Newark 6
Seattle 6
Cagliari 5
Helsinki 5
Istanbul 5
Mexico City 5
Reston 5
Springfield 5
Turin 5
Vancouver 5
Washington 5
Belo Horizonte 4
Brussels 4
Castel Campagnano 4
Charlotte 4
Chennai 4
Cleveland 4
Florence 4
Formia 4
Guayaquil 4
Haiphong 4
Johannesburg 4
Nuremberg 4
Paris 4
Rio de Janeiro 4
Salt Lake City 4
San Gennaro Vesuviano 4
San José 4
San Salvador 4
Stockholm 4
Tianjin 4
Biên Hòa 3
Boydton 3
Brasília 3
Calgary 3
Calitri 3
Campinas 3
Castel Volturno 3
Catania 3
Chaguanas 3
Chennevières-sur-marne 3
City of London 3
Evora 3
Falkenstein 3
Forlì 3
Totale 3.549
Nome #
Abnormal Liver Blood Tests in Patients with Hyperthyroidism: Systematic Review and Meta-Analysis 460
Change in circulating levels of endothelial progenitor cells and sexual function in women with type 1 diabetes 190
Impact of pituitary autoimmunity and genetic disorders on growth hormone deficiency in children and adults 172
Applications for social security benefits related to diabetes in the working age in Italy between 2009 and 2019: a nationwide retrospective cohort study 170
Feasibility of simplification from a basal-bolus insulin regimen to a fixed-ratio formulation of basal insulin plus a glp-1ra or to basal insulin plus an SGLT2 inhibitor: BEYOND, a randomized, pragmatic trial 167
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 166
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression 165
Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes 163
When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes 161
Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial 160
Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS 159
Exploring the performance of ultrasound risk stratification systems in thyroid nodules of pediatric patients 159
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs 158
Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome 157
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues 157
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 156
Prevalence and Management of Complications of Percutaneous Ethanol Injection for Cystic Thyroid Nodules: A Systematic Review of Literature and Meta-analysis 152
Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes 143
Varicocele: An Endocrinological Perspective 142
Assessment of Neuroendocrine Changes and Hypothalamo-Pituitary Autoimmunity in Patients with COVID-19 141
Neuroimmunoendocrinology of SARS-CoV 2 Infection 141
Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial 140
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off 139
Sleep quality and glucose control in adults with type 1 diabetes during the seasonal daylight saving time shifts 134
Unilateral Graves' disease: a case report with concomitant thyroid cancer and systematic review of literature 134
Telemedicine for type 2 diabetes during COVID-19 pandemic: experience from a tertiary diabetes center 134
Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules 132
Simplification of complex insulin therapy: a story of dogma and therapeutic resignation 129
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs 126
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes 126
Patient-specific factors, patient preference, and nodule size as implications in the initial surgery of high risk indeterminate thyroid nodules 123
Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy 119
Mediterranean diet in type 2 diabetes: An updated overview of pharmacological activities of cardiometabolic and reproductive outcomes 119
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs 119
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice 113
Renal and metabolic effects of SGLT-2i and DPP-4i according to basal estimated glomerular filtration rate: Analysis from GIOIA, an observational prospective study 110
Reply to the letter to the editor by Mungmunpuntipantip et al 105
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis 103
Fixed-ratio combination of GLP-1 receptor agonist and basal insulin: simplifying type 2 diabetes treatment 100
Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes 82
Smart insulin pen after pancreatectomy: a successful strategy for managing type 3c diabetes 57
Do Levothyroxine Adjustments During Pregnancy Differ Between Users of Tablet and Nontablet Formulation? A Real-World Study 55
Exploring Insulin Resistance in Adults With Type 1 Diabetes: The Role of the Estimated Glucose Disposal Rate and the Triglyceride Glucose Index 48
Impact of Semaglutide on Limb Events: A Meta-Analysis of Randomized Controlled Trials 42
Real-world glycemic outcomes of a tubeless automated insulin delivery system: a single-center observational study in Italy 39
Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts 38
GLP1-1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta-analysis of randomised controlled trials and cohort studies 38
Real-world safety comparison of liraglutide and semaglutide in weight management: Insights from European pharmacovigilance data 37
The Glycemia Risk Index (GRI) as a Biomarker for Subclinical Endothelial Dysfunction in Type 1 Diabetes: A Cross-Sectional Study 34
Quality of Life After Ethanol Ablation of Thyroid Nodules: A 1-Year Follow-Up Study 32
BEYOND 4 years: simplification of complex insulin regimens with a fixed-ratio combination of basal insulin plus a GLP-1 receptor agonist or basal insulin plus an SGLT-2 inhibitor 27
The effects of GIP, GLP-1 and GLP-2 on markers of bone turnover: a review of the gut-bone axis 26
The therapeutic efficacy of continuous glucose monitoring in diabetes: an updated meta-analysis with meta-regression 26
Response to Letter to the Editor From Maino et al: "Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-Analysis" 25
Totale 6.450
Categoria #
all - tutte 21.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022108 0 0 0 0 9 0 4 3 11 18 5 58
2022/2023452 51 9 9 27 75 27 0 27 203 7 6 11
2023/2024242 25 8 10 23 54 47 14 2 4 9 12 34
2024/2025696 12 14 19 13 114 112 101 51 81 78 61 40
2025/20263.810 176 217 168 164 302 1.859 237 256 144 155 61 71
2026/20271.115 28 166 541 380 0 0 0 0 0 0 0 0
Totale 6.450